Vertex Pharmaceuticals (VRTX): Today's Featured Health Care Loser

Vertex Pharmaceuticals ( VRTX) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.9%. By the end of trading, Vertex Pharmaceuticals fell $1.32 (-2%) to $63.38 on average volume. Throughout the day, 3.9 million shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 3.3 million shares. The stock ranged in price between $62.88-$66.10 after having opened the day at $64.37 as compared to the previous trading day's close of $64.70. Other company's within the Health Care sector that declined today were: Tianyin Pharmaceutical ( TPI), down 32.2%, Rosetta Genomics ( ROSG), down 22.9%, Lakeland Industries ( LAKE), down 20.6%, and Dynatronics Corporation ( DYNT), down 16%.

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for the treatment of serious diseases worldwide. Vertex Pharmaceuticals has a market cap of $13.09 billion and is part of the drugs industry. The company has a P/E ratio of 42.8, below the average drugs industry P/E ratio of 45.3 and above the S&P 500 P/E ratio of 17.7. Shares are up 86.8% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Vertex Pharmaceuticals as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive.

On the positive front, Urologix ( ULGX), up 19.5%, Dynacq Healthcare ( DYII), up 13.4%, Gentiva Health Services ( GTIV), up 11.8%, and Natural Alternatives International ( NAII), up 10.9%, were all gainers within the health care sector with Perrigo Company ( PRGO) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Vertex Pharmaceuticals Could Be Headed Higher Once Again

Omeros Shares Lower After Completing Stock Offering, Juno Dips - Biotech Movers

10 High-Yielding Stocks to Own Ahead of a Surprising Late Summer Market Swoon

Vertex Pharmaceuticals: Looking East, West and to the Quants

Vertex Pharmaceuticals: Looking East, West and to the Quants